PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 13, 2024
Last Patient Enrolled for Planned Unblinded Interim Analysis in Ongoing SHIELD II Phase 3 Trial of D-PLEX100
Unblinded Interim Analysis Outcome Expected Later this Quarter
Read more at globenewswire.com
